Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| CXR-H5222 | Human | Human CXADR / CAR Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Upacicalcet | SK-1403; AJT-240 | Approved | Ajinomoto Co Inc | ウパシタ, Upasita | Japan | Hyperparathyroidism, Secondary | Sanwa Kagaku Kenkyusho Co Ltd | 2021-06-23 | Hyperparathyroidism, Secondary | Details |
| Parathyroid hormone (Shire) | NPSP-795; rhPTH (1-84); rhPTH-1-84; PTH (1-84); SB-423562; PTH 1-84; NPSP-558; SHP-635; SHP-634; ALX-111; 423562; EBP-05; EB-612 | Approved | Shire | Natpara, Preotact, Natpar | United States | Hypoparathyroidism | Nps Pharmaceuticals, Inc | 2006-04-24 | Osteoporosis; Bone Diseases, Endocrine; Osteoporosis, Postmenopausal; Hypocalcemia; Psoriasis; Hypoparathyroidism; Hyperparathyroidism | Details |
| Cinacalcet Hydrochloride | AMG-073.HCl; NPS-1493; AMG-073; KRN-1493 | Approved | Amgen Inc | Parareg, Sensipar, Mimpara, Regpara, 盖平, Sensipar/Mimpara | United States | Hypercalcemia; Hyperparathyroidism, Secondary | Amgen Inc | 2004-03-08 | Hyperparathyroidism, Secondary; Rejection of renal transplantation; Hypophosphatemia; Edema, Cardiac; Parathyroid Neoplasms; Nephrosis; Kidney Diseases; Hypercalcemia; Hyperparathyroidism, Primary; Prostatic Neoplasms; Osteomalacia; Renal Insufficiency, Chronic; Hyperparathyroidism; Kidney Failure, Chronic; Chronic Kidney Disease-Mineral and Bone Disorder | Details |
| Etelcalcetide Hydrochloride | ONO-5163; KAI-4169; AMG-416; KAI-4169-HCl | Approved | Amgen Inc | Parsabiv | EU | Hyperparathyroidism, Secondary | Amgen Europe Bv | 2016-11-11 | Hyperparathyroidism, Secondary; Edema, Cardiac; Renal Insufficiency, Chronic; Kidney Failure, Chronic | Details |
| Strontium Ranelate | S-12911; S-12911-2; FK-481 | Approved | Laboratoires Servier | Osseor, Protos, Protelos, 欧思美 | Mainland China | Osteoporosis, Postmenopausal | Les Laboratoires Servier | 2004-09-20 | Osteoporosis, Postmenopausal | Details |
| Evocalcet | KHK-7580; MT-4580 | Approved | Mitsubishi Tanabe Pharma Corp | Orkedia | Japan | Hyperparathyroidism, Secondary | Kyowa Hakko Kirin Co Ltd | 2018-03-23 | Hyperparathyroidism, Secondary; Parathyroid Neoplasms; Hyperparathyroidism, Primary; Hyperparathyroidism | Details |
| Upacicalcet | SK-1403; AJT-240 | Approved | Ajinomoto Co Inc | ウパシタ, Upasita | Japan | Hyperparathyroidism, Secondary | Sanwa Kagaku Kenkyusho Co Ltd | 2021-06-23 | Hyperparathyroidism, Secondary | Details |
| Parathyroid hormone (Shire) | NPSP-795; rhPTH (1-84); rhPTH-1-84; PTH (1-84); SB-423562; PTH 1-84; NPSP-558; SHP-635; SHP-634; ALX-111; 423562; EBP-05; EB-612 | Approved | Shire | Natpara, Preotact, Natpar | United States | Hypoparathyroidism | Nps Pharmaceuticals, Inc | 2006-04-24 | Osteoporosis; Bone Diseases, Endocrine; Osteoporosis, Postmenopausal; Hypocalcemia; Psoriasis; Hypoparathyroidism; Hyperparathyroidism | Details |
| Cinacalcet Hydrochloride | AMG-073.HCl; NPS-1493; AMG-073; KRN-1493 | Approved | Amgen Inc | Parareg, Sensipar, Mimpara, Regpara, 盖平, Sensipar/Mimpara | United States | Hypercalcemia; Hyperparathyroidism, Secondary | Amgen Inc | 2004-03-08 | Hyperparathyroidism, Secondary; Rejection of renal transplantation; Hypophosphatemia; Edema, Cardiac; Parathyroid Neoplasms; Nephrosis; Kidney Diseases; Hypercalcemia; Hyperparathyroidism, Primary; Prostatic Neoplasms; Osteomalacia; Renal Insufficiency, Chronic; Hyperparathyroidism; Kidney Failure, Chronic; Chronic Kidney Disease-Mineral and Bone Disorder | Details |
| Etelcalcetide Hydrochloride | ONO-5163; KAI-4169; AMG-416; KAI-4169-HCl | Approved | Amgen Inc | Parsabiv | EU | Hyperparathyroidism, Secondary | Amgen Europe Bv | 2016-11-11 | Hyperparathyroidism, Secondary; Edema, Cardiac; Renal Insufficiency, Chronic; Kidney Failure, Chronic | Details |
| Strontium Ranelate | S-12911; S-12911-2; FK-481 | Approved | Laboratoires Servier | Osseor, Protos, Protelos, 欧思美 | Mainland China | Osteoporosis, Postmenopausal | Les Laboratoires Servier | 2004-09-20 | Osteoporosis, Postmenopausal | Details |
| Evocalcet | KHK-7580; MT-4580 | Approved | Mitsubishi Tanabe Pharma Corp | Orkedia | Japan | Hyperparathyroidism, Secondary | Kyowa Hakko Kirin Co Ltd | 2018-03-23 | Hyperparathyroidism, Secondary; Parathyroid Neoplasms; Hyperparathyroidism, Primary; Hyperparathyroidism | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Encaleret sulfate | MK-5442; JTT-305; CLTX-305 | Phase 3 Clinical | Japan Tobacco (Hong Kong) Ltd | Osteoporosis; Hypocalcemia; Osteoporosis, Postmenopausal; Hypoparathyroidism | Details |
| LNP-1892 | LNP-1892 | Phase 2 Clinical | Lupin Ltd | Hyperparathyroidism | Details |
| DS-9194b | DS-9194b | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Osteoporosis | Details |
| OSM-0205 | OSM-0205 | Phase 1 Clinical | Yale University, Osmol Therapeutics Inc | Peripheral Nervous System Diseases; Peripheral Nerve Injuries | Details |
| RT-102(Rani) | RT-102 | Phase 1 Clinical | Rani Therapeutics Holdings Inc | Osteoporosis | Details |
| Encaleret sulfate | MK-5442; JTT-305; CLTX-305 | Phase 3 Clinical | Japan Tobacco (Hong Kong) Ltd | Osteoporosis; Hypocalcemia; Osteoporosis, Postmenopausal; Hypoparathyroidism | Details |
| LNP-1892 | LNP-1892 | Phase 2 Clinical | Lupin Ltd | Hyperparathyroidism | Details |
| DS-9194b | DS-9194b | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Osteoporosis | Details |
| OSM-0205 | OSM-0205 | Phase 1 Clinical | Yale University, Osmol Therapeutics Inc | Peripheral Nervous System Diseases; Peripheral Nerve Injuries | Details |
| RT-102(Rani) | RT-102 | Phase 1 Clinical | Rani Therapeutics Holdings Inc | Osteoporosis | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
